Home/Vaxess Technologies/Rachel Sha

RS

Rachel Sha

CEO

Vaxess Technologies

Therapeutic Areas

Metabolic Diseases (e.g., Obesity, Diabetes)Infectious Disease (Vaccines)

Vaxess Technologies Pipeline

Drug	Indication	Phase
GLP-1 MAP Program	Obesity / Type 2 Diabetes	Pre-clinical